In summary, ADAM17 knockout reduced diabetes-induced collagen synthesis and ameliorated cardiac remodeling through the inhibition of RAAS overactivation when combined with eplerenone treatment, which reducing TGF-β1/Smad3 pathway activation-mediated CMT. Here, TGFB1 is linked to diabetes mellitus.